Contract 75N91026P00014
Invivoscribe, Inc. · Department Of Health And Human Services · March 4, 2026
Invivoscribe, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on March 4, 2026 for $57,000 of work in in-vitro diagnostic substance manufacturing. Performance is in San Diego, CA. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75N91026P00014
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- San Diego, CA
- First action
- March 4, 2026
Description
PURCHASE OF INVIVOSCRIBE IGH +IGK B-CELL CLONALITY ASSAYS
Modification timeline
-
March 4, 2026Base award$57.4K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Biomerieux Inc | Department Of Health And Human Services | March 30, 2026 | $239.5K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91026P00014?
Contract 75N91026P00014 is a federal contract awarded to Invivoscribe, Inc. by Department Of Health And Human Services on March 4, 2026 for $57,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N91026P00014?
Invivoscribe, Inc. won contract 75N91026P00014 from Department Of Health And Human Services.
How much is contract 75N91026P00014 worth?
Contract 75N91026P00014 has obligated $57,000 to date.